Defining and modulating brcaness to improve the precision of prostate cancer therapy
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110264
- Recipient
-
Fred Hutchinson Cancer Research Center UEI HMSNCM57QNR5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,125,843
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Seattle, WA 98109, USA
Award details come from USAspending.gov.
About this award
The Fred Hutchinson Cancer Research Center was awarded a $1,125,843 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) for the period of August 1, 2021 through July 31, 2024.
Under this award, Fred Hutchinson Cancer Research Center will define and modulate BRCANESS to improve the precision of prostate cancer therapy. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions for battlefield medicine and the investigation of medical solutions. This award will further those goals by advancing precision oncology for prostate cancer, a disease that significantly impacts both military service members and civilians.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $1,125,843 |
Quick answers
Who received award W81XWH2110264?
W81XWH2110264 was awarded to Fred Hutchinson Cancer Research Center by Medical Command (Department of the Army) on August 1, 2021.
How much is award W81XWH2110264 worth?
$1,125,843 has been obligated on W81XWH2110264.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award